Anthropic filed Monday for its long-discussed initial public offering, promising to finally convert scores of paper fortunes into real ones.
The maker of the frontier large language model Claude could soon land on Nasdaq under the ticker ANT, according to a Form S-1 filed with the SEC. Goldman Sachs and Morgan Stanley are leading the float.
The valuation
Investors have discussed a valuation of about $1.5 trillion, down from earlier expectations of $2 trillion, after the company’s quarterly revenue growth slowed, according to a Reuters report earlier this month.
The lower number is still a 55% hike from its $965 billion private valuation in May. At a $1.5 trillion valuation, one share of common stock would be worth about $88.60.
Despite not revealing the price range, the more than 300-page prospectus offers a closer look at who invested, what they paid and how much longer they may have to wait to cash out.
Who is selling?
Anthropic’s seven co-founders, including CEO Dario Amodei and President Daniela Amodei, are among the prospective selling stockholders. They will maintain control through a single special share that carries 50.1% of voting power.
The two biggest backers of the company are strategic investors Amazon and Alphabet’s Google. Amazon will use the IPO to convert outstanding debt into equity.
Amazon had $6.2 billion in outstanding convertible notes as of June 30. An IPO would let Anthropic convert some of those notes into shares at prices as low as $2.09 apiece, with a 12% ownership cap, according to the prospectus.
If fully converted, Amazon would own roughly one-fifth of Anthropic’s outstanding shares, according to PitchBook calculations.
Google holds approximately 7% of Anthropic and has an option to invest another $10 billion in nonvoting shares at the IPO price.
Spark Capital is the only pure-play venture firm named in the filing. Its general partner Yasmin Razavi sits on Anthropic’s board. The firm has made six investments in Anthropic since 2023 totaling approximately $777 million, writing checks at $1.12 to $58.90 a share. The shares acquired in those rounds would be worth about $10.9 billion at a $1.5 trillion valuation.
Iconiq has invested more than $6 billion since first backing Anthropic in 2025 at a $183 billion valuation. This stake was worth approximately $17 billion at the latest private valuation, according to Bloomberg.
Retail investors already have indirect exposure to Anthropic through mutual funds. Capital Group held approximately $10 billion in Anthropic investments as of September 30. Fidelity held about $5 billion, according to Morningstar.
Why is Anthropic listing?
For Anthropic, the listing would provide another source of capital.
The company had $131.7 billion in cash and short-term investments at June 30 and generated $3.9 billion in operating cash flow during the first half.
Meanwhile, Anthropic generated nearly $1 billion in operating profit in the second quarter, compared with a $1.2 billion operating loss a year earlier, according to the S-1.
The company reported an $80.7 billion net loss for the first half. Nearly 90% of that—$72.4 billion—is in the form of noncash charges, mostly tied to the rising value of convertible notes.
By converting some notes at the IPO, part of the charge would go away.
The other chunk of Anthropic’s obligations is from spending commitments for chips and data centers.
Anthropic owes at least $114.5 billion to Google through 2033 and $110 billion to Amazon through 2036, according to the S-1.
Some shareholders will have to wait until the lock-up period expires before getting their whole turkey dinner.
Non-founder directors, officers and employees may sell 10% of their holdings on the first trading day and 35% more after full-year results. Everyone else on the standard 180-day lock-up is let out in slices.
Some shareholders have already sold. In April, a tender offer allowed employees and other insiders to sell $4.66 billion of Anthropic shares at $25.91 apiece. Both Amodei siblings were among the sellers in this secondary process, according to the prospectus. Some institutional investors could be in the waiting line for longer.
Secondary-market prices had already implied a valuation of about $1.57 trillion as of Oct. 12, according to AG Dillon & Co.
Latest Research
Healthtech Report: Healthy Deal Environment About to Run Into Difficult Comps
Learn about our editorial standards.